title: A case of taxane-induced scleroderma: a different expression profile of Fli1 proteins in dermal fibroblasts and microvascular endothelial cells compared with systemic sclerosis.
authors.forename: T
authors.initials: T
authors.lastname: Takahashi
authors.forename: Y
authors.initials: Y
authors.lastname: Asano
authors.forename: Y
authors.initials: Y
authors.lastname: Ichimura
authors.forename: T
authors.initials: T
authors.lastname: Taniguchi
authors.forename: A
authors.initials: A
authors.lastname: Kogure
authors.forename: Z
authors.initials: Z
authors.lastname: Tamaki
authors.forename: T
authors.initials: T
authors.lastname: Takekoshi
authors.forename: M
authors.initials: M
authors.lastname: Sugaya
authors.forename: S
authors.initials: S
authors.lastname: Sato
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy; D001952:Bridged-Ring Compounds / Q000009:adverse effects*; D042783:Endothelial Cells / Q000378:metabolism*; D005260:Female; D005347:Fibroblasts / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D008840:Microfilament Proteins / Q000378:metabolism*; D008875:Middle Aged; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism*; D012595:Scleroderma, Systemic / Q000139:chemically induced* / Q000378:metabolism; D012867:Skin / Q000378:metabolism; D043823:Taxoids / Q000009:adverse effects*; D015534:Trans-Activators
chemical_list: D000970:Antineoplastic Agents; D001952:Bridged-Ring Compounds; C098179:FLII protein, human; D008840:Microfilament Proteins; D018160:Receptors, Cytoplasmic and Nuclear; D043823:Taxoids; D015534:Trans-Activators; C080625:taxane